LONDON BROKER RATINGS: Deutsche Bank cuts Fevertree price target

(Alliance News) - The following London-listed shares received analyst recommendations Monday ...

Alliance News 16 September, 2024 | 8:39AM
Email Form Facebook Twitter LinkedIn RSS

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:

----------

FTSE 100

----------

Deutsche Bank cuts Melrose Industries target to 560 (675) pence - 'hold'

----------

RBC raises Marks & Spencer price target to 400 (350) pence - 'outperform'

----------

Barclays raises Marks & Spencer price target to 400 (360) pence - 'overweight'

----------

UBS raises Sainsbury's price target to 321 (295) pence - 'buy'

----------

FTSE 250

----------

Deutsche Bank cuts Renishaw price target to 4,000 (4,500) pence - 'hold'

----------

Deutsche Bank cuts Morgan Advanced Materials target to 320 (335) pence - 'hold'

----------

Berenberg raises JTC price target to 1,400 (1,300) pence - 'buy'

----------

JPMorgan cuts Spire Healthcare price target to 321 (344) pence - 'overweight'

----------

AIM

----------

Deutsche Bank cuts Fevertree Drinks target to 1,325 (1,450) pence - 'buy'

----------

Deutsche Bank raises Gamma Communications target to 2,300 (2,250) pence 'buy'

----------

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Fevertree Drinks PLC 775.50 GBX 1.17 -
Gamma Communications PLC 1,700.00 GBX 0.95 -
JTC PLC Ordinary Shares 1,134.00 GBX 3.85 -
Morgan Advanced Materials PLC 284.00 GBX -2.07 -
Melrose Industries PLC 467.20 GBX -2.57
Sainsbury (J) PLC 294.60 GBX 1.66
Marks & Spencer Group PLC 361.40 GBX 2.90
Renishaw PLC 3,375.00 GBX -0.74 -
Spire Healthcare Group PLC 235.50 GBX -3.29 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures